Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis?

被引：11
|
作者：
Samos, Matej [1 ]
Fedor, Marian [2 ]
Kovar, Frantisek [1 ]
Duraj, Lukas [2 ]
Stanciakova, Lucia [2 ]
Galajda, Peter [1 ]
Stasko, Jan [2 ]
Kubisz, Peter [2 ]
Mokan, Marian [1 ]
机构：
[1] Comenius Univ, Jessenius Fac Med Martin, Dept Internal Med 1, Kollarova 2, Martin 03659, Slovakia
[2] Comenius Univ, Jessenius Fac Med Martin, Dept Hematol & Blood Transfus, Natl Ctr Hemostasis & Thrombosis, Martin 03659, Slovakia
来源：
BLOOD COAGULATION & FIBRINOLYSIS | 2016年 / 27卷 / 02期
关键词：
high on-treatment platelet reactivity; percutaneous coronary intervention; stent thrombosis; ticagrelor; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; PRASUGREL; PRETREATMENT; EFFICACY; IMPACT;
D O I：
10.1097/MBC.0000000000000406
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Stent thrombosis is a morbid complication following percutaneous coronary intervention (PCI). Dual antiplatelet therapy significantly reduces stent thrombosis risk. However, the antiplatelet response to clopidogrel - the most frequently used ADP receptor antagonist in post-PCI patients - varies among individuals. High on-treatment platelet reactivity was repeatedly associated with the risk of stent thrombosis. Ticagrelor is a novel ADP receptor blocker that has shown greater, more rapid and more consistent platelet inhibition than clopidogrel. This agent offers a unique mechanism of action, no relevant pharmacological interactions, consistent platelet inhibition, and a good safety profile. This article reviews the prospective use of ticagrelor in the treatment of stent thrombosis in acute coronary syndrome patients undergoing PCI of culprit coronary lesion. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码：117 / 120
页数：4
相关论文
共 50 条
  • [21] Ticagrelor versus clopidogrel for prevention of subclinical stent thrombosis detected by optical coherence tomography in patients with drug-eluting stent implantation-a multicenter and randomized study
    Wu, Xiangqi
    You, Wei
    Wu, Zhiming
    Wu, Qiang
    Jiang, Jun
    Yan, Hua
    Ye, Fei
    Chen, Shaoliang
    PLATELETS, 2021, 32 (03) : 404 - 412
  • [22] Is a high maintenance dose of clopidogrel suitable for overcoming clopidogrel resistance in patients?
    Choi, Ho
    Ryu, JiHyeon
    Seo, Heenam
    Kang, MinKu
    Kim, Eunyoung
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (05) : 758 - 761
  • [23] High Maintenance Dosage of Clopidogrel is Associated with a Reduced Risk of Stent Thrombosis in Clopidogrel-Resistant Patients
    Neda Tavassoli
    Sophie Voisin
    Didier Carrie
    Maryse Lapeyre-Mestre
    Michel Galinier
    Jean Louis Montastruc
    Atul Pathak
    American Journal of Cardiovascular Drugs, 2010, 10 : 29 - 35
  • [24] Safety and Effectiveness of Ticagrelor in Patients With Clopidogrel Resistance Undergoing Angioplasty, Stent or Flow Diverter Placement
    Hassan, Ameer E.
    Shariff, Umar
    Qureshi, Adnan
    STROKE, 2018, 49
  • [25] A case of subacute thrombosis associated with clopidogrel resistance after implantation of a zotarolimus-eluting stent
    Arima, Mizuhiro
    Matsuda, Atsushi
    Nitta, Manabu
    Yoshida, Keiko
    Shimizu, Makoto
    HEART AND VESSELS, 2012, 27 (01) : 106 - 109
  • [26] Effects of genetic factors to stent thrombosis due to clopidogrel resistance after coronary stent placement
    Kirac, D.
    Erdem, A.
    Avcilar, T.
    Yesilcimen, K.
    Guney, A. I.
    Emre, A.
    Yazici, S.
    Terzi, S.
    Kaspar, E. C.
    Cetin, S. E.
    Isbir, T.
    CELLULAR AND MOLECULAR BIOLOGY, 2016, 62 (01) : 51 - 55
  • [27] Pharmacotherapeutic Considerations for the Use of Prasugrel and Ticagrelor to Reduce Stent Thrombosis in Patients With Acute Coronary Syndrome
    Piccolo, Raffaele
    Di Gioia, Giuseppe
    Niglio, Tullio
    D'Anna, Carolina
    De Rosa, Roberta
    Strisciuglio, Teresa
    Bevilacqua, Michele
    Piscione, Federico
    Cirillo, Plinio
    Galasso, Gennaro
    ANGIOLOGY, 2014, 65 (02) : 130 - 136
  • [28] Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes: An Analysis From the Prospective, Randomized PLATO Trial
    Steg, P. Gabriel
    Harrington, Robert A.
    Emanuelsson, Hakan
    Katus, Hugo A.
    Mahaffey, Kenneth W.
    Meier, Bernhard
    Storey, Robert F.
    Wojdyla, Daniel M.
    Lewis, Basil S.
    Maurer, Gerald
    Wallentin, Lars
    James, Stefan K.
    CIRCULATION, 2013, 128 (10) : 1055 - 1065
  • [29] Challenging ticagrelor's claimed reduction in the rate of definite stent thrombosis versus clopidogrel: Insights from the FDA reports
    DiNicolantonio, James J.
    Biondi-Zoccai, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 633 - 635
  • [30] Factors that contribute to clopidogrel resistance in cardiovascular disease patients: environmental and genetic approach
    Al-Azzam, Sayer I.
    Alzoubi, Karem H.
    Khabour, Omar F.
    Nusair, Mohammad B.
    Al-Hadidi, Hakam
    Awidi, Abdalla
    Saleh, Akram
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (03) : 179 - 186
12345